Media Centre NewsJune 4, 2024FDA Clears Genetic Signatures’ Molecular Diagnostic Solution for Gastrointestinal ParasitesNewsJune 4, 2024Genetic Signatures Appoints Former Roche Diagnostics Executive Allison Rossiter as CEONewsApril 30, 2024Genetic Signatures farewells long-standing CEO & Director, Dr. John MelkiWebinarDecember 14, 202339th NRL Workshop on Infectious Disease Testing- October 2023EventsMarch 14, 2024BDL 2024EventsNovember 21, 2023KMIS 2023EventsNovember 1, 2023SMA 2023EventsOctober 20, 2023Global Health Exhibition 2023EventsOctober 20, 2023SCASM 2023EventsOctober 3, 2023DKLM 2023EventsOctober 3, 2023National Reference Laboratory Workshop on Infectious Diseases 2023BlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into Israel
NewsJune 4, 2024FDA Clears Genetic Signatures’ Molecular Diagnostic Solution for Gastrointestinal Parasites
NewsJune 4, 2024Genetic Signatures Appoints Former Roche Diagnostics Executive Allison Rossiter as CEO
BlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into Israel